Colorectal Cancer Clinical Trial
Official title:
Improving Systems for Colorectal Cancer Screening
RATIONALE: Screening may help doctors find colorectal cancer sooner, when it may be easier
to treat. Computerized and mailed reminders may help increase the rate of colorectal cancer
screening in adults with an average risk for colorectal cancer.
PURPOSE: This randomized clinical trial is studying how well computerized and mailed
reminders work in increasing the rate of colorectal cancer screening in adults with an
average risk for colorectal cancer.
OBJECTIVES:
Primary
- Determine whether rates of colorectal cancer (CRC) screening can be increased among
average-risk adults by using patient-specific, active, electronic, clinical reminders
for primary care physicians during office visits and mailed reminders and fecal occult
blood test cards for patients.
Secondary
- Calculate baseline rates of CRC screening, in terms of patient demographic
characteristics, primary care physician, and practice group, by using computerized
clinical information systems to identify patients due for screening.
- Assess baseline rates of CRC screening among patients insured by different health
plans.
- Determine whether the impact of the interventions is related to efforts by health plans
to promote CRC screening.
- Evaluate patients' willingness to use a validated web-based tool to estimate their
personal risk of CRC.
OUTLINE: This is a randomized, controlled study. Patients are randomized to 1 of 2 arms
(arms I or III). Physicians are randomized to 1 of 2 arms (arms II or IV).
- Arm I: Patients receive mailed reminders for colorectal cancer (CRC) screening.
Patients also receive fecal occult blood testing (FOBT) instructions and cards.
Patients who remain overdue for screening at 6 months after the initial mailing receive
a follow-up letter reminding them of their need to be screened. Patients who return
positive FOBT cards undergo colonoscopy within 1 month. The patient's primary care
physician may receive computerized screening reminders at the time of the patient's
office visit and may order CRC screening tests online.
- Arm II: Patients receive no mailings. The patient's primary care physician may receive
computerized screening reminders at the time of the patient's office visit and may
order CRC screening tests online.
- Arm III: Patients receive mailed reminders for CRC screening. The patient's primary
care physician may order CRC screening tests online, but will not receive active
computerized reminders. Patients also receive FOBT instructions and cards. Patients who
remain overdue for screening at 6 months after the initial mailing receive a follow-up
letter reminding them of their need to be screened. Patients who return positive FOBT
cards will be scheduled to undergo colonoscopy within 1 month.
- Arm IV: Patients receive no mailings. The patient's primary care physician may order
CRC screening tests online, but will not receive active computerized reminders.
Patients are followed for 15 months to determine screening rates.
PROJECTED ACCRUAL: A total of 21,860 patients will be accrued for this study.
;
Allocation: Randomized, Primary Purpose: Screening
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |